Securities code: Novogene Co.Ltd(688315) securities abbreviation: Novogene Co.Ltd(688315) Announcement No.: 2022007
Novogene Co.Ltd(688315)
Announcement on adjusting the members of the special committee of the second board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Novogene Co.Ltd(688315) (hereinafter referred to as “the company”) convened the first extraordinary general meeting of shareholders in 2022 on March 8, 2022, deliberated and adopted the proposal on electing Mr. Pan Weijiang as an independent director of the second board of directors of the company, and elected Mr. Pan Weijiang as an independent director of the second board of directors of the company, The term of office starts from the date of deliberation and approval by the general meeting of shareholders to the date of expiration of the second board of directors. In view of the personnel adjustment of the board of directors, in accordance with the relevant provisions of the company law, the articles of association and the working rules of the special committees of the board of directors, the company held the 23rd Meeting of the second board of directors on the same day as the general meeting of shareholders, deliberated and adopted the proposal on adjusting the members of the special committees of the second board of directors, It is agreed to elect Mr. Pan Weijiang as a member of the audit committee, nomination committee and remuneration and assessment committee of the second session of the board of directors of the company. The term of office starts from the date of adoption of the current board of directors to the date of expiration of the term of office of the second session of the board of directors, and other committee members remain unchanged.
The members of the special committee of the second board of directors of the company are as follows:
1. The audit committee of the second session of the board of directors is composed of Ms. Zhang Ran, Mr. Pan Weijiang and Mr. Li Xiao, and the chairman is Ms. Zhang Ran.
2. The nomination committee of the second board of directors is composed of Ms. Zhang Ran, Mr. Pan Weijiang and Mr. Li Ruiqiang, and the chairman is Mr. Li Ruiqiang.
3. The remuneration and assessment committee of the second board of directors is composed of Ms. Zhang Ran, Mr. Pan Weijiang and Mr. Wang Qifeng, and the chairman is Ms. Zhang Ran.
4. The strategy committee of the second board of directors is composed of Mr. Li Ruiqiang, Mr. Wang Qifeng and Mr. Li Xiao, and the chairman is Mr. Li Ruiqiang.
It is hereby announced.
Novogene Co.Ltd(688315) board of directors March 9, 2022
